Heriot-Watt University Featured PhD Programmes
University of Leicester Featured PhD Programmes
Anglia Ruskin University Featured PhD Programmes
University of Kent Featured PhD Programmes
University of Bristol Featured PhD Programmes

Understanding the molecular mechanisms which drive brain cancer recurrence and defining novel therapies to target these aggressive tumour cell populations

  • Full or part time
  • Application Deadline
    Friday, February 01, 2019
  • Competition Funded PhD Project (Students Worldwide)
    Competition Funded PhD Project (Students Worldwide)

Project Description

Glioblastoma (GBM) is the most common and aggressive adult primary brain cancer. Median survival is <15 months and only about 10% of patients survive two years without disease recurrence. Therefore, there is a critical need to search for new and innovative approaches to patient management and treatment. It is well understood that GBM cells are adaptive to chemotherapy and radiation treatment which is the cause for tumour recurrence and subsequent death. The mechanisms that lead to this recurrence are poorly understood.

As part of the QIMR-Berghofer Brain Cancer Tissue Bank, we have collected a series of patient specimens which include primary tumours that have not undergone treatment and matching post-treatment recurrent tumours. This is a valuable and rare resource. We are utilising these pair-matched specimens and cell cultures to elucidate how malignant brain tumours develop resistance. By understanding the molecular functions that cause treatment resistance, we will be able to design therapies to prevent recurrence and improve patient outcomes.

The aim of this project will be to understand how these aggressive tumours reform following therapy by undertaking an in-depth analysis of pre- and post-treatment paired GBM specimens. We believe that to significantly improve outcomes for patients with GBM we first need to understand in detail how tumour cells can survive standard therapies and recur. Once differences between multiple primary and recurrent GBM specimens have been identified, the project will aim to validate candidate therapeutic targets in preclinical animal models. Outcomes from this project will include the definition of novel molecular mechanism’s associated with recurrence and potentially define novel therapies suitable for testing in clinical trial. Ultimately these therapies could prolong the life of sufferers of these incurable diseases.

For more information on this research group: http://www.qimrberghofer.edu.au/lab/sid-faithfull-brain-cancer-laboratory/

Funding Notes

The Sid Faithfull Brain Cancer Lab is offering a PhD Scholarship for a top applicant. For details, application form and eligibility criteria please contact Courtney Jurd -

Provide an academic CV and transcripts in your introduction email.

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully

FindAPhD. Copyright 2005-2019
All rights reserved.